The immune profiles and 'minimizing tacrolimus'strategy for long-term survival recipients after liver transplantation

摘要

cqvip:To the Editor:Liver transplantation(LT)has become a major and effective therapeutic approach for end-stage liver disease[1].However,10-year graft and patient survival rates remained low with 54%and 61%,respectively[2].Improving the outcome of long-term LT has become a major focus of the transplantation community.